Literature DB >> 21562051

TNF blockade abrogates the induction of T cell-dependent humoral responses in an allotransplantation model.

Gabriela FrancoSalinas1, Hoa-Le Mai, Voja Jovanovic, Frédérique Moizant, Bernard Vanhove, Francoise Boeffard, Claire Usal, Paul P Tak, Jean-Paul Soulillou, Dominique Baeten, Sophie Brouard.   

Abstract

TNF blockade modulates many aspects of the immune response and is commonly used in a wide array of immune-mediated inflammatory diseases. As anti-TNF induces anti-dsDNA IgM antibodies but not other antinuclear reactivities in human arthritis, we investigated here the effect of TNF blockade on the induction of TD humoral responses using cardiac allograft and xenograft models. A single injection of an anti-rat TNF antibody in LEW.1A recipients grafted with congenic LEW.1W hearts almost completely abrogated the induction of IgM and IgG alloantibodies. This was associated with decreased Ig deposition and leukocyte infiltration in the graft at Day 5. TNF blockade did not affect germinal-center formation in the spleen or expression of Th1/Th2 cytokines, costimulatory and regulatory molecules, and TLRs in spleen and graft of the recipient animals. Clinically, the abrogation of the induction of the alloantibodies was associated with a marked prolongation of graft survival. In contrast, anti-TNF did not alter acute xenograft rejection mediated by TI antibodies in a hamster-to-rat model. Taken together, these data indicate that TNF blockade abrogates the induction of TD humoral responses and accordingly, may have a beneficial effect in antibody-mediated inflammatory pathologies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21562051     DOI: 10.1189/jlb.0710392

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  3 in total

1.  Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction.

Authors:  Michelle Yap; Françoise Boeffard; Emmanuel Clave; Annaick Pallier; Richard Danger; Magali Giral; Jacques Dantal; Yohann Foucher; Cécile Guillot-Gueguen; Antoine Toubert; Jean-Paul Soulillou; Sophie Brouard; Nicolas Degauque
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

Review 2.  Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.

Authors:  Karina Yazdanbakhsh; Russell E Ware; France Noizat-Pirenne
Journal:  Blood       Date:  2012-05-04       Impact factor: 22.113

3.  Anti-TNF-α therapy in membranous glomerulonephritis.

Authors:  Domenico Santoro; Adele Postorino; Giuseppe Costantino; Vincenzo Savica; Guido Bellinghieri
Journal:  Clin Kidney J       Date:  2012-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.